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Abstract
The continually increasing antibiotic resistance amongst microorganisms had steered up an increased intensity in the search 
for new drugs. The marine environment had been reported to be a great source of novel compounds with diverse biological activi-
ties and this had engendered the attention of researcher globally, but the West African Coast despite being blessed with a variety of 
Macro-algae remain untapped. This study was, therefore, embarked upon to investigate the antibacterial activities of selected green 
algal species from the West African coast. Crude extracts of Ulva fasciata, Ulva lactuca, Chladophora vagabunda, Caulepa taxifolia, 
Chaetomorpha antennina and Chaetomorpha linum were obtained by maceration using Dichloromethane/methanol (DCM/MeOH), 
chloroform/methanol (CHL/MeOH) 90% (v/v), Ethanol and Diethyl ether as solvents. Extracts were screened against some bacterial 
pathogens including Gram-positive bacteria- clinical strain (Sa I), S. aureus laboratory strain (Sa II), S. aureus ATCC 25922 (Sa III), 
Bacillus subtilis (Bs), Streptococcus pneumonia (Sp), Streptococcus faecalis (Sf) and Mycobacterium aurum (Ma). Gram-negative test 
bacteria were Escherichia coli clinical (Ec I) and Escherichia coli laboratory strain (Ec II), Escherichia coli NCTC 10418 (Ec III), E. coli 
ATCC 25923 (Ec IV), Proteus vulgaris (Pv), Proteus mirabilis (Pm), Pseudomonas aeruginosa (Pa) Pseudomonas putida (Pp), Salmo-
nella typhi clinical strain (St I), Salmonella typhi NCTC 8385 (St II), Serratia macerans (Sm) and Klebsiella pneumonia (Kp). Crude 
extracts were obtained using Antibacterial screening was carried out by disc diffusion method. The result analysis was done by mean 
± SD. The result showed that all the screened algae had antibacterial activity against at least one of the test organisms. Four (57%) of 
the seven algal species tested demonstrated inhibitory activities against the Gram-positive test bacteria while all the seven species 
tested showed inhibitory activities against the Gram-negative test bacteria. Highest inhibitory zone against Gram-negative bacterial 
species was observed in dichloromethane/methanol extract of Caulepa taxifolia (DCCT) against E. coli measuring 14.67 mm while 
the highest activity against Gram-positive bacterial strain was observed in diethyl acetate extract of Chaetomorpha antennina (DECA) 
against S. aureus (SaII) with an inhibitory zone of 17.67 mm. Extracts of Chaetomorpha antennina showed the highest inhibitory 
activities in this study. The result of this study showed that extracts from species of green macro-algae from the West African Coast 
possess antibacterial compounds that can serve as lead drug candidates in the quest for new antibacterial therapy if well explored. 
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Introduction
Seaweeds or marine algae are macroscopic, attached or freely floating plants. They form one of the essential marine living, renewable 
resources. They are primitive plants without any real root, stem and leaves. They belong to the division of Thallophyta in the plant 
kingdom. Marine algae are classified into four groups namely Chlorophyceae (green algae), Phaeophyceae (brown algae), Rhodophyceae 
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(red algae) and Cyanophyceae (blue-green algae) based on the type of pigments, morphological, anatomical and reproductive structures 
[1]. Green algae occur in a wide variety of shapes and sizes. Sea lettuce (Ulva sp.), sea grapes (Caulerpa) and turtle grass (Chlorodesmis) 
are some of the most abundant types of green algae on coral reefs where they play an essential role. 
The use of seaweeds in medicine dates back to 300 BC with the Japanese and Chinese cultures using seaweed to treat goiter and other 
glandular problems. The Romans used seaweeds in the treatment of wounds, burns and rashes. The use of dried seaweeds in Scotland 
dates back to the 18th century when physicians used dried seaweed stem to drain abdominal wall abscesses successfully. Seaweeds were 
also reportedly used in the treatment of dysmenorrhea [2]. Seaweeds are one of the critical marine living resources in the world. These 
macroalgae have been a source of food, feed and medicine in the east as well as in the west, since ancient times [3,4]. Orient countries 
such as Japan, China and Korea nutritionally consume about (5%) of green algae, (66.5%) of brown algae and (33%) of red algae in daily 
diets [5-7]. Dietary seaweeds provide all essential minerals. Seaweeds can provide minerals often absent from freshwater and food crops 
grown on mineral-depleted soils and therefore serve as nutraceuticals [8]. Seaweeds are consumed as food, animal fodder, fertilizer, 
industrial material such as agar and minor medicines.
Marine algae produce a cocktail of metabolites with exciting biological activities (anti-infective, anti-inflammatory and anti-
proliferative) and with potential commercial value [9-12]. The marine environment has reportedly been described as an exceptional 
reservoir of bioactive natural products, many of which exhibit structural/chemical features not found in terrestrial natural products 
[13]. Natural products remain the most prolific source of new antimicrobials and the chemical diversity of natural compounds is still 
unmatched by combinatorial chemistry approaches [14-15]. Seaweeds or marine algae have been reported to contain many substances 
such as alginate, carrragenean and agar as phycocolliods that have been used for decades in medicine and pharmacy. More chemists 
and biologists pay attention to the constituents of the algae; if their natural products are explored, they may give a qualified lead to 
the discovery of new drug molecules against several pathogens infectious diseases [16]. Kotimchencko and co-workers [17] reported 
that sulphated polysaccharides from marine algae inhibited tumor growth and the metastatic process by direct action on tumor cells 
and by enhancement of immune response. Oral administration of several seaweeds can cause a significant decrease in the incidence of 
carcinogenesis in vivo. 
Reports have shown that a large number of algal extract products have antimicrobial activities [18]. Many of the structures were 
identified as fatty acids and hydroxyl unsaturated fatty acids, glycolipids, steroids, phenolics and terpenoids. Lauric acid, palmitic acid, 
linolenic acid, oleic acid, stearic acids are known to be potential antibiotic or antifungal agents. Most bioactive compounds extracted 
from seaweeds have been applied for their biocidal (anti-fungi, antibacterial) and pharmaceutical activities [16]. Reports have shown the 
antibacterial activities of some algal extracts against multidrug-resistant bacteria [19,20]. Many other reports of antioxidant activities of 
macroalgae have also been reported [19,21-23].
The use of marine natural products capable of inhibiting bacteria offers productive pharmacological potential and crude extracts 
obtained from various seaweeds using different solvents have been reported to exhibit inhibitory activities. This study was, therefore, 
aimed at screening selected species of green marine macro-algae for antibacterial activities against human pathogens.
Materials and Method
Sample Collection: Algal samples were obtained from the Ghana coasts between May 2013 and August 2014. Species of fresh algae 
were collected by detaching them manually from rock surfaces at low tides. Some other samples were collected using a knife at low tides 
to avoid intense wave action. These samples were immediately kept under the ice in an ice-box and transported to the laboratory where 
they were sorted out and then thoroughly cleaned with fresh water. Samples obtained were adequately identified as Ulva fasciata, Ulva 
lactuca, Chladophora vagabunda, Caulepa taxifolia, Chaetomorpha antennina and Chaetomorpha linum. Samples were properly labeled 
with voucher numbers- Ulva fasciata -PB0513UF, Ulva lactuca -SA0513UL, Caulepa taxifolia –PB0513CT, Chaetomorpha antennina- 
SA0513CA and Chaetomorpha linum- PB0513CL. They were kept frozen until the extraction period. Sample specimens were dropped in 
the Crawford University herbarium with their voucher numbers. The sampling locations were shown in the figure below (Figure 1).
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Figure 1: Location map of sampling sites.
Sampling sites
The different sampling sites were explored. Details of these sites are seen on the map. The green algae in this study were obtained from 
Mighty and Paradise Mighty Beaches at the shores of Ghanaian Coast.
Sample preparation and crude extraction
The algae were cleaned to remove epiphytes and debris and thereafter washed thoroughly in tap water and later with distilled water. 
Samples were then shade dried for seven days. Dried sample was pulverized using milling machine. Powdered sample was extracted with 
Diethyl ether, Dichloromethane/Methanol (ratio 2:1), 90% Ethanol, Chloroform/ Methanol [24]. Fifty grams of sample was extracted in 
300ml of solvent. This was heated to 37oC and held for 30 minutes and the supernatant was filtered. The process was repeated twice. 
The extract was later concentrated using the Rotary evaporator (Buchi 200, Germany) at 40oC. Extract concentrate was then stored in the 
freezer till needed.
Antibacterial assay
Collection and preparation of test organisms
Bacterial strains
Bacterial strains were obtained from the Lagos University Teaching Hospital, (LUTH) (Staphylococcus aureus clinical and laboratory 
strains, Bacillus subtilis, Streptococcus pneumoniae, Streptococcus faecalis, Gram negative species Escherichia coli (clinical and laboratory 
strain), E. coli NCTC 10418, Pseudomonas aeruginosa, Salmonella typhi (clinical strain), Salmonella typhi NCTC 8385 and Klebsiella 
pneumoniae) and some others were obtained from the department of Life Sciences, Rhodes University, Grahamstown, South Africa 
comprising of both Gram-positive (S. aureus ATCC 25922, Mycobacterium aurum and Gram-negative strains including E. coli ATCC 25923, 
Proteus vulgaris, Proteus mirabilis, Pseudomonas putida). These bacterial samples were used as the test organisms and their identity was 
confirmed using appropriate biochemical tests according to standard procedures [25].
Disc diffusion method
The disc diffusion method was carried out using the method of Bauer and co workers [26] as adopted by other researchers [27,28]. 
The bacterial suspensions were standardized by MacFarland standard 0.5, which is equivalent to 108 CFU/ml. Plain discs of 6 mm were 
produced from Whatman’s filter paper no. 1 and sterilized in the oven at 60oC overnight. These discs were soaked with known quantity 
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of extracts and allowed to dry completely. The dry discs containing the extracts were then placed on Petri plates containing solidified 
Mueller Hinton Agar seeded with test bacteria and incubated at 37oC for 48 hours. All tests were done in triplicates. Gentamycin (10 μg) 
and Ciprofloxacin (10 μg) were used as standard antibiotics.
Minimum inhibitory concentration (MIC)
The Minimum Inhibitory Concentration was carried out against the strains of S. aureus and E. coli tested [30]. Potency test was carried 
out using the disk diffusion method while MIC values of the extracts were obtained using the broth micro-dilution method. Sterile 96-well 
micro-plates were used for the assay (0.5 ml volume, Fisher Scientific). 
Statistical analysis was done by Mean ± SD.
Results
The algal yield ranged from 2.22% in Caulepa taxifolia to 8.88% in Chaetomorpha anteninna. Antibacterial activities of the crude 
extracts are shown in figure 2-5. Inhibitory activity was observed in all the extract against at least two pathogens except for ethanol 
extract, which showed inhibitory activity in C. taxifolia (ETCT) against Gram-negative bacteria. Diethyl extracts of U. fasciata (DEUF) 
and C. anteninna (DECA) showed inhibitory activities against the strains of S. aureus tested with zones of inhibition ranging from 9.33 
mm in U. fasciata and 17.67 mm in C. anteninna. The diethyl ether extract of the alga Ulva fasciata (DEUF) showed a zone of inhibition 
of (13.67 mm) against Proteus mirabilis, while 9.33 mm, 11.17 mm and 12 mm zones of inhibition were observed against Sa I, Sa II and 
Sa III, the different strains of S. aureus respectively. The inhibitory activities of extracts of this solvent against Gram-negative bacteria 
ranged between 8.00 mm in C. vagabunda (DECV) and 15.33 mm in C. anteninna (DECA). The Diethyl ether of C. vagabunda only showed 
inhibitory activity against Gram-negative bacterial strains. For the chloroform/methanol extracts, the algae C. vagabunda (CHCV) and 
C. taxifolia (CHCT) showed no inhibitory activities against the tested Gram-positive pathogens but C. taxifolia (CHCT) showed a zone of 
inhibition ranging from 11.17 mm to 14.67 mm against the E. coli strains. The chloroform/methanol extract of C. anteninna showed broad-
spectrum activities inhibiting both Gram-positive and Gram-negative pathogens with zones of inhibition ranging from 10.00 mm to 11.17 
mm against S. aureus strains and 7.33 mm to 10.67 mm against E. coli strains. The minimum inhibitory concentration (MIC) of the extracts 
was obtained against strains of E. coli and S. aureus (Table 2) and the lowest MIC value obtained is 640 μg as observed in U. fasciata, C. 
vagabunda and C. taxifolia against E. coli as well as in U. lactuca and C. anteninna against S. aureus.
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Figure 3: Antibacterial Activities of Ulva lactuca extracts.
Figure 4: Antibacterial activities of C. vagabunda extracts.
Figure 5: Antibacterial activities of C. antennina extracts.
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Discussion
The yield percentage of the algae ranged between 2.22% and 8.88%. Virtually all the algal species showed antibacterial activities 
against several of the test bacterial strains tested. All solvent extracts were positive for activity displaying either broad or narrow 
spectrum activities. The alga, Ulva fasciata exhibited broad-spectrum antibacterial activity. Activities were observed against five out of 
seven test Gram-positive bacteria strains while it showed inhibitory activity against five out of eleven Gram-negative bacterial strains. The 
inhibitory zones ranged from 6.67 to 13.67 mm. Priyadshini., et al. [29] reported inhibitory activities of this alga against V. alginolyticus 
and Enterobacter sp. while Paulert., et al. [30] reported that extract of U. fasciata was inhibitory against P. aeruginosa, X. campestris and 
Ewinia carotovora. In this study, it was observed that the different solvents extracts of U. fasciata (DEUF, DCUF and CHUF) all inhibited 
the three strains of Staphylococcus aureus, Bacillus subtilis and Mycobacterium aurium as well as the E. coli strains and P. mirabilis tested. 
The activities of extracts of U. fasciata had been reported against multidrug-resistant organisms. Pramintha and Lipton [31] reported 
the antibacterial activities of U. fasciata against multidrug resistant S. aureus, P. aeruginosa and V. alginoluticus with inhibitory zones 
ranging between 15 mm and 18 mm. The report of Chandrasekaran., et al. [32] also revealed the inhibitory activities of U. fasciata against 
B. substilis with the mean zones of inhibition (15.0 mm), S. pyogenes (14.0 mm), E. coli (13.6 mm) and P. mirabilis (13.3 mm). This is 
comparable to the result of this study in which B. substilis has a mean zone of inhibition (13.33 mm), S. aureus (8.00-12.0 mm), E. coli 
(6.67 - 11.17 mm) and P. mirabilis (13.67 mm). U. fasciata from the West African coast could be a source of novel bioactive compounds that 
could of therapeutic intervention against pathogenic bacteria and even multidrug-resistant bacteria.
In this study, the macro-algae Ulva lactuca and Chaetomorpha antennina both displayed broad-spectrum antibacterial activities against 
bacterial test strains. Ulva lactuca extracts in this study positive bacterial strains tested with the lowest inhibitory zone of 7.17 mm 
observed in chloroform: methanol extract against Sa III and the highest zone of inhibition of 15.67 mm observed against Sa III while 
6.67 mm and 12.67 mm were the lowest and highest inhibitory zones observed against Gram-negative strains. The family Ulvaceae had 
previously been reported for different antimicrobial activities against human pathogens [33] and such reports corroborate this result. 
Algal species Location Weight of Algae (g) Weight of extract (g) Extract yield % Extract color
Ulva fasciata Ghana 500 43.35 8.67 Greyish green
Ulva lactuca Ghana 100 8.50 8.50 Light green
Chladophora vagabunda Ghana 20 1.58 7.92 Deep green
Caulepa taxifolia Ghana 100 2.22 2.22 Dirty green
Chaetomorpha antennina Ghana 50 4.44 8.88 Light green
Chaetomorpha linum Ghana 50 3.83 7.65 Light green
Table 1: Extract yield of algal samples.
Algal species and standard antibiotics E. coli I (µg) S. aureus I (µg)
Ulva fasciata 640 > 640
Ulva lactuca > 640 640
Cladophora vagabunda 640 ND
Caulepa taxifolia 640 No activity
Chaetomorpha anteninna 640 640
Chaetomorpha linum > 640 No activity
Ciprofloxacin 5 5
Gentamycin 5 5
Table 2: Minimum Inhibitory Concentration of some of the dichloromethane/methanol extracts against E. coli and S. aureus strains.
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The activities of this C. anteninna against multidrug-resistant bacteria had also been reported [34]. Activity was observed against 
strains of E. coli, S. aureus, P. vulgaris and P. putida with inhibitory zones ranging from 7.33 mm in E. coli I to 17.67 mm in S. aureus (Sa II) 
at a concentration of 100 μg/ml. Sivarkumar., et al. [35] reported inhibitory activities of this algal extract against S. aureus, E. coli and by P. 
aeruginosa at the concentration of 50 μg/ml with zones of inhibition of 7.3 ± 0.8 mm against S. aureus, 8 ± 0.6 mm against E. coli and 7.3 ± 
1 mm for P. aeruginosa. The observed activity in this study even revealed much higher inhibitory zones than those reported, S. aureus -Sa 
II strain tested showed a zone of 17.67 mm as against 7.3 mm reported by Sivarkumar and co-workers [37].
The extracts of C. taxiofolia, C. vagabunda and C. linum displayed a narrow-spectrum activity by inhibitory activity against Gram-
negative. The report of Muha mmad and Abu-Dobara is at variance with this present study because no activity was observed from C. 
taxifolia against their test bacteria. The report of Chandrasekaran., et al. [32] revealed that productive inhibitory activity of a species of the 
genus Caulepa (C. racemosa) was active against vancomycin resistant E. faecalis. Also, Etcherla and Rao reported the inhibitory activities 
of C. taxifolia against Bacillus subtillis and Micrococcus luteus and the fungus Candida albicans. The selective activity of these three green 
algae against Gram-negative test bacteria may be a function of the mechanism of action which could be cell wall-related. The MIC results 
of the tested crude extracts revealed that most of the extracts had a MIC of 640 µg. For crude extract to show a MIC as low as 640 µg means 
the algae are promising and should, therefore, be further researched [36,37]. 
Significant Statement
Various species are available at this coast with little attention regarding utilization and exploration. This study discovered that some 
green algal species from the West African Coast could be beneficial in the quest for new antimicrobials if well explored. This study will 
help project the possible health benefits that can be obtained from these species as regards medicinal effects. Hence, forming a basis for 
more exploration and critical studies of these species.
Conclusion
This study revealed that the crude extracts of the selected green algae all have potential inhibitory activities against selected bacterial 
strains tested. The West African Coast is having so much of these algal species and as such should be a center of attraction for future 
studies of these macroalgae with the inclusion of isolation of active principle, which may be readily utilized for the development of new 
drugs.
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